日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/11/24 | 1,649 | 1,651 | 1,631 | 1,640 | +1 | +0.1% | 6,500 |
| 2023/11/22 | 1,636 | 1,651 | 1,636 | 1,639 | +13 | +0.8% | 3,900 |
| 2023/11/21 | 1,634 | 1,644 | 1,626 | 1,626 | +9 | +0.6% | 2,200 |
| 2023/11/20 | 1,634 | 1,638 | 1,617 | 1,617 | ±0 | ±0% | 5,200 |
| 2023/11/17 | 1,620 | 1,625 | 1,617 | 1,617 | -3 | -0.2% | 2,900 |
| 2023/11/16 | 1,626 | 1,628 | 1,620 | 1,620 | ±0 | ±0% | 2,800 |
| 2023/11/15 | 1,625 | 1,628 | 1,620 | 1,620 | ±0 | ±0% | 4,400 |
| 2023/11/14 | 1,631 | 1,638 | 1,620 | 1,620 | -5 | -0.3% | 3,100 |
| 2023/11/13 | 1,628 | 1,633 | 1,625 | 1,625 | +5 | +0.3% | 2,200 |
| 2023/11/10 | 1,628 | 1,630 | 1,620 | 1,620 | -3 | -0.2% | 8,400 |
| 2023/11/09 | 1,620 | 1,628 | 1,620 | 1,623 | +3 | +0.2% | 1,600 |
| 2023/11/08 | 1,635 | 1,640 | 1,614 | 1,620 | -15 | -0.9% | 9,800 |
| 2023/11/07 | 1,663 | 1,668 | 1,630 | 1,635 | -28 | -1.7% | 9,200 |
| 2023/11/06 | 1,674 | 1,687 | 1,661 | 1,663 | -5 | -0.3% | 14,000 |
| 2023/11/02 | 1,699 | 1,709 | 1,668 | 1,668 | -40 | -2.3% | 7,300 |
| 2023/11/01 | 1,655 | 1,713 | 1,655 | 1,708 | +57 | +3.5% | 15,200 |
| 2023/10/31 | 1,647 | 1,718 | 1,646 | 1,651 | +5 | +0.3% | 9,500 |
| 2023/10/30 | 1,724 | 1,729 | 1,646 | 1,646 | -97 | -5.6% | 11,900 |
| 2023/10/27 | 1,750 | 1,750 | 1,738 | 1,743 | -7 | -0.4% | 1,800 |
| 2023/10/26 | 1,766 | 1,772 | 1,750 | 1,750 | -25 | -1.4% | 3,200 |
| 2023/10/25 | 1,794 | 1,794 | 1,773 | 1,775 | +1 | +0.1% | 3,800 |
| 2023/10/24 | 1,789 | 1,789 | 1,760 | 1,774 | -20 | -1.1% | 10,300 |
| 2023/10/23 | 1,802 | 1,802 | 1,791 | 1,794 | -8 | -0.4% | 5,600 |
| 2023/10/20 | 1,810 | 1,820 | 1,802 | 1,802 | -14 | -0.8% | 3,500 |
| 2023/10/19 | 1,811 | 1,816 | 1,803 | 1,816 | +7 | +0.4% | 6,200 |
| 2023/10/18 | 1,811 | 1,811 | 1,803 | 1,809 | -1 | -0.1% | 1,400 |
| 2023/10/17 | 1,836 | 1,842 | 1,806 | 1,810 | -34 | -1.8% | 10,200 |
| 2023/10/16 | 1,844 | 1,844 | 1,844 | 1,844 | +4 | +0.2% | 100 |
| 2023/10/13 | 1,847 | 1,847 | 1,836 | 1,840 | -15 | -0.8% | 700 |
| 2023/10/12 | 1,840 | 1,858 | 1,835 | 1,855 | +15 | +0.8% | 4,700 |
| 2023/10/11 | 1,864 | 1,894 | 1,836 | 1,840 | -26 | -1.4% | 5,100 |
| 2023/10/10 | 1,855 | 1,866 | 1,855 | 1,866 | +13 | +0.7% | 1,400 |
| 2023/10/06 | 1,847 | 1,853 | 1,847 | 1,853 | +6 | +0.3% | 800 |
| 2023/10/05 | 1,849 | 1,849 | 1,833 | 1,847 | +10 | +0.5% | 3,200 |
| 2023/10/04 | 1,850 | 1,851 | 1,837 | 1,837 | -20 | -1.1% | 3,100 |
| 2023/10/03 | 1,872 | 1,872 | 1,849 | 1,857 | -15 | -0.8% | 2,600 |
| 2023/10/02 | 1,872 | 1,884 | 1,872 | 1,872 | ±0 | ±0% | 2,100 |
| 2023/09/29 | 1,924 | 1,925 | 1,871 | 1,872 | -52 | -2.7% | 2,300 |
| 2023/09/28 | 1,920 | 1,924 | 1,910 | 1,924 | -17 | -0.9% | 1,700 |
| 2023/09/27 | 1,901 | 1,941 | 1,901 | 1,941 | +30 | +1.6% | 5,900 |
| 2023/09/26 | 1,916 | 1,923 | 1,888 | 1,911 | -6 | -0.3% | 6,200 |
| 2023/09/25 | 1,900 | 1,934 | 1,900 | 1,917 | +32 | +1.7% | 2,200 |
| 2023/09/22 | 1,885 | 1,902 | 1,869 | 1,885 | ±0 | ±0% | 6,700 |
| 2023/09/21 | 1,895 | 1,895 | 1,885 | 1,885 | -5 | -0.3% | 2,500 |
| 2023/09/20 | 1,920 | 1,923 | 1,888 | 1,890 | -30 | -1.6% | 4,100 |
| 2023/09/19 | 1,919 | 1,921 | 1,914 | 1,920 | +1 | +0.1% | 7,900 |
| 2023/09/15 | 1,918 | 1,919 | 1,900 | 1,919 | +9 | +0.5% | 4,000 |
| 2023/09/14 | 1,880 | 1,910 | 1,880 | 1,910 | +33 | +1.8% | 2,800 |
| 2023/09/13 | 1,877 | 1,877 | 1,868 | 1,877 | -10 | -0.5% | 2,200 |
| 2023/09/12 | 1,871 | 1,887 | 1,867 | 1,887 | +16 | +0.9% | 2,900 |
351～
400
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 145,500円 | +2.5% | - | 3.44% | 87.49倍 | 0.28倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ＯＴＳ | 2,300円 | +63.9% | - | 0.00% | - | 6.85倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ノイルイミューン | 14,500円 | -28.6% | - | 0.00% | - | 1.33倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| ペルセウス | 41,400円 | +20.0% | - | 0.00% | - | 3.47倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| ＮＰＴ | - | - | - | - | - | - |
|
- |
市場注目の銘柄
チャート関連のコラム
